Indicator disease-guided testing for HIV--the next step for Europe?

TY - JOUR

T1 - Indicator disease-guided testing for HIV--the next step for Europe?

AU - Gazzard, B

AU - Clumeck, N

AU - d'Arminio Monforte, A

AU - Lundgren, J D

N1 - Keywords: AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Europe; Female; HIV Infections; Health Policy; Humans; Immune System Diseases; Male; Mandatory Testing; Pregnancy; Pregnancy Complications, Infectious

PY - 2008

Y1 - 2008

N2 - HIV should preferably be diagnosed in its earlier stages. To optimize the chances of doing so, HIV testing in patients presenting with one of several indicator diseases and conditions is recommended. Patients presenting with tuberculosis and other AIDS-defining conditions should be tested. Patients with sexually transmitted diseases should be offered an HIV test, as should patients with certain types of cancers and laboratory abnormalities. Governments should consider adopting opt-out testing for pregnant women. These recommendations should be considered for implementation by all types of health professionals across Europe, and audits to study the extent of their being followed, conducted and reported to the European AIDS Clinical Society webpage (http://www.eacs.eu).

AB - HIV should preferably be diagnosed in its earlier stages. To optimize the chances of doing so, HIV testing in patients presenting with one of several indicator diseases and conditions is recommended. Patients presenting with tuberculosis and other AIDS-defining conditions should be tested. Patients with sexually transmitted diseases should be offered an HIV test, as should patients with certain types of cancers and laboratory abnormalities. Governments should consider adopting opt-out testing for pregnant women. These recommendations should be considered for implementation by all types of health professionals across Europe, and audits to study the extent of their being followed, conducted and reported to the European AIDS Clinical Society webpage (http://www.eacs.eu).

U2 - 10.1111/j.1468-1293.2008.00592.x

DO - 10.1111/j.1468-1293.2008.00592.x

M3 - Journal article

C2 - 18557871

SN - 1464-2662

VL - 9 Suppl 2

SP - 34

EP - 40

JO - HIV Medicine

JF - HIV Medicine

ER -